LRRK2 and nonpapillary renal cell carcinoma: The epidermal growth factor receptor (EGFR) signaling pathway plays a critical role in the pathogenesis and progression of renal cell carcinoma [16, 17], suggested that LRRK2 may play an important role in ccRCC as well.